Futura Medical (LON:FUM) Announces Earnings Results

Futura Medical (LON:FUM) posted its quarterly earnings results on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Trading Down 12.9%

Shares of FUM stock opened at GBX 0.33 on Wednesday. Futura Medical has a 12-month low of GBX 0.24 and a 12-month high of GBX 10.45. The stock’s 50-day moving average price is GBX 0.42 and its 200-day moving average price is GBX 0.79. The stock has a market capitalization of £1.92 million, a price-to-earnings ratio of -0.12 and a beta of 0.02.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.